PEACHI-03 Hepatitis C Vaccine Trial We are looking for volunteers to take part in our Hepatitis C vaccine trial. If you are aged 18-65 and in good health, you could be eligible to participate. We are seeking volunteers who have never been exposed to HCV and also those who were previously infected but have since been cured with all oral therapies. The study involves 12 visits over a period of 8 months and volunteers will be reimbursed up to £505 for their time, inconvenience and travel. For more detailed information about this trial, please click here.
TB041 Tuberculosis Vaccine Trial We are looking for volunteers in the Oxford area for a BCG challenge trial in healthy adults to help develop TB vaccines. If you are aged 18-50, in good health, have never received BCG and have not taken part in a trial or study where TB trial vaccines have been used, you may be eligible to participate. Participants will be reimbursed for their time and travel from £575 to £635. For more detailed information about this trial, please click here.
HR HPV Study Defining the high risk human papillomavirus (HR HPV) specific T-cell repertoire in human subjects using a proteome wide approach. For more detailed information about this trial, please click here.
VAC068 Malaria Challenge Study A study to investigate the safety of P. vivax malaria infection by mosquito bite, and assess parasite growth and immune responses. This study is over a 3-month month period and volunteers will be compensated up to £3,255 for their time, inconvenience and travel. If you are aged 18-50, have blood group O negative, are in good health, and never had malaria, you may be eligible to participate For more detailed information about this trial, please click here.
To find out if you are eligible to take part in one of our trials, please click on the relevant age range below:
If you would like to register with us to receive an email newsletter detailing our latest trials, please click here (- opens in a new tab). If you live outside Oxfordshire, you may be interested in the clinical vaccine trials taking place in Southampton and Birmingham.